Alkermes Statistics
NASDAQ: ALKSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
40.11-1.34 (-3.22%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Alkermes by the numbers
Alkermes has a market capitalization of $6.73 billion based on 167.76M shares outstanding. Its trailing P/E ratio is 105.6, above the 3-company peer median of 40.1, and its forward P/E is 22.2. The stock trades 13.1% below its 50-day average and 1.9% above its 200-day average.
Average daily trading volume is 1.86M shares, or about $74.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALKS valuation vs. peer median
| Metric | ALKS | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.73B | $6.51B | +3% |
| P/E (TTM) | 105.6 | 40.1 | +163% |
| Forward P/E | 22.2 | 36.7 | -40% |
| Avg. volume | 1.86M | 614.01K | +202% |
Peer median across 8 companies: AMRX, IONS, RYTM, KNSA, BLTE, PRAX, SYRE, LGND.
Valuation
- Market cap
- $6.73B
- P/E (TTM)
- 105.55
- Forward P/E
- 22.18
- Price / sales (latest FY)
- 4.56
- EPS (TTM)
- $0.38
- Shares outstanding
- 167.76M
Price and trading
- Previous close
- 41.45
- Open
- 41.10
- Day range
- 39.11 – 41.26
- 52-week range
- 27.00 – 55.67
- 52-week change
- +27.29%
- Beta
- —
- Volume
- 3.24M
- Average volume
- 1.86M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 27, 2026
Additional statistics
- Market Cap
- 6.73B
- Pe
- 105.55
- Forward Pe
- 22.18
- Eps
- 0.38
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 55.67
- Week52 Low
- 27.00
- Avg Volume
- 1.86M
- Shares Outstanding
- 167.76M
- Ma50
- 46.18
- Ma200
- 39.36
- Earnings Date
- Oct 27, 2026
- Pct From52w High
- -27.95%
- Pct From52w Low
- 48.56%